Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2016 1
2019 2
2020 1
2021 1
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).
Chiva L, Ordás P, Martin-Calvo N, Aramendia JM, Sanchez Lorenzo L, Gallego Martínez A, Vizcay Á, Minguez JA, Manzour N, Vázquez-Vicente D, Chacon E, Castellanos T, Gonzalez Martin A. Chiva L, et al. Among authors: sanchez lorenzo l. Int J Gynecol Cancer. 2024 Mar 13:ijgc-2024-005354. doi: 10.1136/ijgc-2024-005354. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38479803
[Ansprechen follikulotroper Mycosis fungoides auf Capecitabin].
Estenaga A, Sanchez-Lorenzo L, Antoñanzas-Pérez J, Morelló-Vicente A, Oteiza-Rius I, Cuns CA, Wells J, García-Martínez FJ. Estenaga A, et al. Among authors: sanchez lorenzo l. J Dtsch Dermatol Ges. 2023 Jul;21(7):792-794. doi: 10.1111/ddg.15066_g. J Dtsch Dermatol Ges. 2023. PMID: 37427732 German. No abstract available.
Response of folliculotropic mycosis fungoides to capecitabine.
Estenaga A, Sanchez-Lorenzo L, Antoñanzas-Pérez J, Morelló-Vicente A, Oteiza-Rius I, Cuns CA, Wells J, García-Martínez FJ. Estenaga A, et al. Among authors: sanchez lorenzo l. J Dtsch Dermatol Ges. 2023 Jul;21(7):792-794. doi: 10.1111/ddg.15066. Epub 2023 Apr 25. J Dtsch Dermatol Ges. 2023. PMID: 37186164 No abstract available.
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.
Garcia-Casado Z, Oaknin A, Mendiola M, Alkorta-Aranburu G, Antunez-Lopez JR, Moreno-Bueno G, Palacios J, Yubero A, Marquez R, Gallego A, Sanchez-Heras AB, Lopez-Guerrero JA, Perez-Segura C, Barretina-Ginesta P, Alarcon J, Gaba L, Marquez A, Matito J, Cueva J, Palacio I, Iglesias M, Arcusa A, Sanchez-Lorenzo L, Guerra-Alia E, Romero I, Vivancos A. Garcia-Casado Z, et al. Among authors: sanchez lorenzo l. J Pers Med. 2022 Nov 4;12(11):1842. doi: 10.3390/jpm12111842. J Pers Med. 2022. PMID: 36579549 Free PMC article.
Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.
López-Guerrero JA, Mendiola M, Pérez-Fidalgo JA, Romero I, Torres A, Recalde D, Molina E, Gómez-Raposo C, Levin AM, Herrero A, Alarcón J, Esteban C, Marquina G, Rubio MJ, Guerra E, Sánchez-Lorenzo L, Gálvez-Montosa F, de Juan A, Churruca C, Gallego A, González-Martín A. López-Guerrero JA, et al. Among authors: sanchez lorenzo l. Cancers (Basel). 2022 Apr 13;14(8):1965. doi: 10.3390/cancers14081965. Cancers (Basel). 2022. PMID: 35454870 Free PMC article.
The BRCA Gene in Epithelial Ovarian Cancer.
Sánchez-Lorenzo L, Salas-Benito D, Villamayor J, Patiño-García A, González-Martín A. Sánchez-Lorenzo L, et al. Cancers (Basel). 2022 Feb 27;14(5):1235. doi: 10.3390/cancers14051235. Cancers (Basel). 2022. PMID: 35267543 Free PMC article. Review.
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial.
Gonzalez Martin A, Sanchez Lorenzo L, Colombo N, dePont Christensen R, Heitz F, Meirovitz M, Selle F, van Gorp T, Alvarez N, Sanchez J, Marqués C. Gonzalez Martin A, et al. Among authors: sanchez lorenzo l. Int J Gynecol Cancer. 2021 Apr;31(4):617-622. doi: 10.1136/ijgc-2020-001633. Epub 2020 Dec 14. Int J Gynecol Cancer. 2021. PMID: 33318079 Clinical Trial.
14 results